1. Home
  2. EVO vs LOB Comparison

EVO vs LOB Comparison

Compare EVO & LOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • LOB
  • Stock Information
  • Founded
  • EVO 1993
  • LOB 2008
  • Country
  • EVO Germany
  • LOB United States
  • Employees
  • EVO N/A
  • LOB N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • LOB Major Banks
  • Sector
  • EVO Health Care
  • LOB Finance
  • Exchange
  • EVO Nasdaq
  • LOB Nasdaq
  • Market Cap
  • EVO 1.6B
  • LOB 1.5B
  • IPO Year
  • EVO 2021
  • LOB 2015
  • Fundamental
  • Price
  • EVO $4.44
  • LOB $31.98
  • Analyst Decision
  • EVO Buy
  • LOB Buy
  • Analyst Count
  • EVO 2
  • LOB 4
  • Target Price
  • EVO $5.90
  • LOB $44.75
  • AVG Volume (30 Days)
  • EVO 46.1K
  • LOB 210.0K
  • Earning Date
  • EVO 11-06-2024
  • LOB 01-22-2025
  • Dividend Yield
  • EVO N/A
  • LOB 0.37%
  • EPS Growth
  • EVO N/A
  • LOB 3.05
  • EPS
  • EVO N/A
  • LOB 1.69
  • Revenue
  • EVO $866,665,179.00
  • LOB $402,944,000.00
  • Revenue This Year
  • EVO $3.84
  • LOB N/A
  • Revenue Next Year
  • EVO $10.94
  • LOB $18.70
  • P/E Ratio
  • EVO N/A
  • LOB $19.44
  • Revenue Growth
  • EVO N/A
  • LOB 3.04
  • 52 Week Low
  • EVO $2.85
  • LOB $31.03
  • 52 Week High
  • EVO $7.98
  • LOB $50.57
  • Technical
  • Relative Strength Index (RSI)
  • EVO 49.82
  • LOB 29.15
  • Support Level
  • EVO $4.40
  • LOB $34.57
  • Resistance Level
  • EVO $4.49
  • LOB $35.66
  • Average True Range (ATR)
  • EVO 0.10
  • LOB 1.08
  • MACD
  • EVO -0.00
  • LOB -0.11
  • Stochastic Oscillator
  • EVO 38.46
  • LOB 2.63

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

Share on Social Networks: